Annual EBIT
$38.80 M
+$240.14 M+119.27%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual earnings before interest & taxes is $38.80 million, with the most recent change of +$240.14 million (+119.27%) on December 31, 2023.
- During the last 3 years, AMLX annual EBIT has risen by +$78.79 million (+197.02%).
- AMLX annual EBIT is now at all-time high.
Performance
AMLX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$39.46 M
+$13.98 M+26.16%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly earnings before interest & taxes is -$39.46 million, with the most recent change of +$13.98 million (+26.16%) on September 30, 2024.
- Over the past year, AMLX quarterly EBIT has dropped by -$58.18 million (-310.78%).
- AMLX quarterly EBIT is now -295.33% below its all-time high of $20.20 million, reached on June 30, 2023.
Performance
AMLX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$213.09 M
-$58.18 M-37.56%
September 30, 2024
Summary
- As of February 7, 2025, AMLX TTM earnings before interest & taxes is -$213.09 million, with the most recent change of -$58.18 million (-37.56%) on September 30, 2024.
- Over the past year, AMLX TTM EBIT has dropped by -$205.36 million (-2658.43%).
- AMLX TTM EBIT is now -649.17% below its all-time high of $38.80 million, reached on December 31, 2023.
Performance
AMLX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AMLX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +119.3% | -310.8% | -2658.4% |
| 3 y3 years | +197.0% | -310.8% | -2658.4% |
| 5 y5 years | +411.9% | -310.8% | -2658.4% |
AMLX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.3% | -295.3% | +67.7% | -649.2% | at low |
| 5 y | 5-year | at high | +119.3% | -295.3% | +67.7% | -649.2% | at low |
| alltime | all time | at high | +119.3% | -295.3% | +67.7% | -649.2% | at low |
Amylyx Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$39.46 M(-26.2%) | -$213.09 M(+37.6%) |
| Jun 2024 | - | -$53.44 M(-56.2%) | -$154.91 M(+90.6%) |
| Mar 2024 | - | -$122.13 M(-6414.9%) | -$81.28 M(-309.5%) |
| Dec 2023 | $38.80 M(-119.3%) | $1.93 M(-89.7%) | $38.80 M(-602.3%) |
| Sep 2023 | - | $18.72 M(-7.3%) | -$7.72 M(-90.5%) |
| Jun 2023 | - | $20.20 M(-1084.0%) | -$81.13 M(-47.9%) |
| Mar 2023 | - | -$2.05 M(-95.4%) | -$155.58 M(-22.7%) |
| Dec 2022 | -$201.34 M | -$44.59 M(-18.4%) | -$201.34 M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$54.68 M(+0.8%) | -$185.06 M(+20.7%) |
| Jun 2022 | - | -$54.25 M(+13.5%) | -$153.30 M(+30.3%) |
| Mar 2022 | - | -$47.81 M(+68.9%) | -$117.63 M(+42.3%) |
| Dec 2021 | -$82.69 M(+106.8%) | -$28.32 M(+23.5%) | -$82.69 M(+31.3%) |
| Sep 2021 | - | -$22.92 M(+23.3%) | -$62.96 M(+57.2%) |
| Jun 2021 | - | -$18.59 M(+44.4%) | -$40.05 M(+86.6%) |
| Mar 2021 | - | -$12.87 M(+49.8%) | -$21.46 M(+149.8%) |
| Dec 2020 | -$39.99 M(+221.5%) | -$8.59 M | -$8.59 M |
| Dec 2019 | -$12.44 M | - | - |
FAQ
- What is Amylyx Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual EBIT year-on-year change?
- What is Amylyx Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly EBIT year-on-year change?
- What is Amylyx Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals TTM EBIT year-on-year change?
What is Amylyx Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of AMLX is $38.80 M
What is the all time high annual EBIT for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual earnings before interest & taxes is $38.80 M
What is Amylyx Pharmaceuticals annual EBIT year-on-year change?
Over the past year, AMLX annual earnings before interest & taxes has changed by +$240.14 M (+119.27%)
What is Amylyx Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of AMLX is -$39.46 M
What is the all time high quarterly EBIT for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly earnings before interest & taxes is $20.20 M
What is Amylyx Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, AMLX quarterly earnings before interest & taxes has changed by -$58.18 M (-310.78%)
What is Amylyx Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of AMLX is -$213.09 M
What is the all time high TTM EBIT for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high TTM earnings before interest & taxes is $38.80 M
What is Amylyx Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, AMLX TTM earnings before interest & taxes has changed by -$205.36 M (-2658.43%)